Cyfra 21-1 serum concentration is not a suitable tumor marker for early
diagnosis of squamous cell carcinoma of the oropharynx and there are no significant
correlation between its serum level at the time of initial diagnosis and the
clinicopathological parameters. An abrupt increase of Cyfra 21-1 in serial
measurements during follow-up, indicate impending disease progression or distant
metastases in the individual patient
Alkotyfa, Khaled (139120076): Cyfra 21-1 als Follow-up-Tumormarker bei Patienten mit Plattenepithelkarzinom des Oropharynx. : Philipps-Universität Marburg 2009-10-09. DOI: https://doi.org/10.17192/z2009.0557.
License
This item has been published with the following license: In Copyright
